pharmaphorum| News & views on pharma and biotech’s evolving future

Digital

pharmaphorum podcast Episode 274, Erik Janssen, UCB

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

News

Pharma body sees 'green shoots' in UK investment

The UK is starting to benefit from a "real partnership" between pharma and government, reversing years of diminishing investment, says the ABPI.

Digital

Deep Dive AI 2026

News

UK's Claret Capital raises €575m for European biotechs

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

News

Novo Nordisk's IL-6 drug flunks two more heart trials

Novo Nordisk has opted to discontinue two late-stage trials of IL-6 inhibitor ziltivekimab in heart failure, after taking an interim look at the data.

Featured Content

Digital

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

Digital

Deep Dive AI 2026

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Digital

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Sponsored

From Alzheimer’s disease research to the real-world setting:...

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.

Newsletters and Deep Dive
digital magazine

Latest News

News

Pharma body sees 'green shoots' in UK investment

The UK is starting to benefit from a "real partnership" between pharma and government, reversing years of diminishing investment, says the ABPI.

News

UK's Claret Capital raises €575m for European biotechs

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

News

Novo Nordisk's IL-6 drug flunks two more heart trials

Novo Nordisk has opted to discontinue two late-stage trials of IL-6 inhibitor ziltivekimab in heart failure, after taking an interim look at the data.

News

Novartis hit as Lp(a) drug fails cardio outcomes trial

Novartis shares have slipped after it revealed its Lp(a)-targeted drug, pelacarsen, failed to reduce cardiovascular risks in a major phase 3 trial.

Views & Analysis

Digital

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

Digital

Cyber resilience: Protecting tomorrow's therapies before the...

As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.

Market Access

The EU Joint Clinical Assessment in practice: Early lessons

Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.

Sales & Marketing

One year later, EVERSANA plans to go beyond the AI agency

At an event in New York City, EVERSANA shared updates, customer perspectives, and future plans for its AI agency, which is moving beyond that mandate.